Who owns AMLX?
Institutional ownership of Amylyx Pharmaceuticals Inc. from Form 13F, Q2 2026
207 institutional managers reported holding Amylyx Pharmaceuticals Inc. (AMLX) in Form 13F filings for Q2 2026, with 115,473,611 shares worth $2.1B. The largest reported holder was FMR LLC. Managers that filed both quarters added a net 373,378 shares (+0.3%). 48 opened new positions and 13 sold out.
- Funds holding
- 207
- Value held
- $2.1B
- New / sold out
- 48 / 13
- Net shares, same filers
- +0.3%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of AMLX
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| FMR LLC | $300M | 14.5% | 16,727,909 | Added |
| BlackRock, Inc. | $159M | 7.6% | 8,827,085 | Unchanged |
| Perceptive Advisors LLC | $150M | 7.2% | 8,334,882 | Added |
| TCG Crossover Management, LLC | $112M | 5.4% | 6,243,812 | Unchanged |
| Commodore Capital LP | $101M | 4.9% | 5,650,000 | Unchanged |
| Jupiter Topco LLC | $94.0M | 4.5% | 5,236,102 | First report |
| Saturn V Capital Management LP | $83.0M | 4.0% | 4,624,101 | Added |
| Vanguard Capital Management LLC | $75.9M | 3.7% | 4,224,224 | Added |
| Morgan Stanley | $56.2M | 2.7% | 3,130,808 | Added |
| Driehaus Capital Management LLC | $54.5M | 2.6% | 3,036,970 | Added |
| First Light Asset Management, LLC | $54.3M | 2.6% | 3,023,256 | Trimmed |
| Franklin Resources Inc | $53.0M | 2.6% | 2,950,225 | Added |
| Goldman Sachs Group Inc | $51.3M | 2.5% | 2,858,239 | Added |
| State Street Corp | $46.8M | 2.3% | 2,603,337 | Added |
| Geode Capital Management, LLC | $41.9M | 2.0% | 2,335,315 | Added |
| JPMorgan Chase & Co | $34.9M | 1.6% | 1,863,650 | Added |
| Adage Capital Partners GP, L.l.c. | $34.1M | 1.6% | 1,900,000 | Trimmed |
| Siren, L.L.C. | $26.6M | 1.3% | 1,480,586 | Added |
| Eventide Asset Management, LLC | $23.8M | 1.1% | 1,327,536 | Trimmed |
| 683 Capital Management, LLC | $23.0M | 1.1% | 1,279,512 | Trimmed |
| Vanguard Portfolio Management LLC | $19.1M | 0.9% | 1,061,534 | Added |
| Alyeska Investment Group, L.P. | $18.9M | 0.9% | 1,053,015 | New |
| Almitas Capital LLC | $17.5M | 0.8% | 974,881 | Trimmed |
| Nantahala Capital Management, LLC | $17.5M | 0.8% | 973,368 | Added |
| Dimensional Fund Advisors LP | $16.2M | 0.8% | 902,463 | Unchanged |
Share of 13F holdings is each fund's shares as a share of the 115,473,611 AMLX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- JPMorgan Chase & Co Added+$31.9M
- Alyeska Investment Group, L.P. New+$18.9M
- Morgan Stanley Added+$17.2M
- Aberdeen Group plc New+$13.2M
- Franklin Resources Inc Added+$12.4M
- Nantahala Capital Management, LLC Added+$7.9M
- Two Sigma Investments, LP Added+$7.7M
- Nearwater Capital Markets, Ltd New+$7.6M
- Trexquant Investment LP New+$6.3M
- Ensign Peak Advisors, Inc New+$5.5M
Biggest sellers in Q2 2026
- Adage Capital Partners GP, L.l.c. Trimmed-$29.8M
- Almitas Capital LLC Trimmed-$20.6M
- Great Point Partners LLC Trimmed-$18.9M
- Stempoint Capital LP Trimmed-$17.2M
- Barclays PLC Trimmed-$16.4M
- Deutsche Bank Ag\ Trimmed-$12.7M
- Jones Hill Capital LP Trimmed-$12.7M
- Bank of America Corp Trimmed-$9.1M
- ADAR1 Capital Management, LLC Trimmed-$9.1M
- Balyasny Asset Management L.P. Trimmed-$7.6M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $212M and sold $202M; 71 added and 57 trimmed.
Schedule 13D and 13G filings on AMLX
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-01-30VANGUARD GROUP INC SCHEDULE 13G filed by Amylyx Pharmaceuticals Inc.Schedule 13G
- 2025-10-07FMR LLC SCHEDULE 13G filed by Amylyx Pharmaceuticals Inc.Schedule 13G
- 2025-07-29VANGUARD GROUP INC SCHEDULE 13G filed by Amylyx Pharmaceuticals Inc.Schedule 13G
- 2025-07-17BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2025-06-25Point72 Asset Management, L.P. SCHEDULE 13G filed by Amylyx Pharmaceuticals Inc.Schedule 13G
- 2025-05-12Adage Capital Management, L.P. SCHEDULE 13G filed by Amylyx Pharmaceuticals Inc.Schedule 13G
- 2025-01-14Point72 Asset Management, L.P. SCHEDULE 13G filed by Amylyx Pharmaceuticals Inc.Schedule 13G
Questions about AMLX ownership
- Who owns AMLX stock?
- 207 institutional investment managers reported AMLX positions in their Form 13F filings for Q2 2026, holding 115,473,611 shares worth $2.1B in total. FMR LLC reported the largest position.
- Are funds buying or selling AMLX?
- In Q2 2026, 48 managers opened new AMLX positions, 71 added, 57 trimmed and 13 sold out. Managers that filed in both quarters added a net 373,378 shares.
- How current is this AMLX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to AMLX by CUSIP. Options are left out. AMLX news and filings · AMLX insider trades · Top funds